Incision Company Profile

Background

Founded in 2014 by Prof. Dr. Theo Wiggers and a dedicated team of medical professionals, Incision is a healthcare technology company headquartered in Amsterdam, Netherlands. The company is committed to transforming surgical education and perioperative care by providing accessible, high-quality digital solutions. Incision's mission is to empower operating room (OR) teams with the knowledge and tools necessary to deliver the highest standard of care. Their vision is to create aligned and confident OR teams operating on processes that are less siloed, less laborious, and less error-prone, thereby improving efficiency and performance collectively.

Key Strategic Focus

Incision's strategic focus centers on enhancing surgical performance and education through digital innovation. The company's core objectives include:

• Developing Comprehensive Digital Solutions: Creating platforms that consolidate critical surgical information, such as surgeon-specific workflows and preference cards, into intuitive applications.

• Expanding Educational Resources: Offering accredited courses and training programs to upskill surgical teams and standardize procedures.

• Integrating Advanced Technologies: Utilizing artificial intelligence (AI) to optimize workflows, data modeling, and product development, ensuring scalability and adaptability to evolving healthcare needs.

Incision primarily targets perioperative teams, including surgeons, nurses, and sterile processing departments, aiming to improve clinical preparedness and operational outcomes. The company operates within the healthcare technology industry, focusing on surgical education and performance enhancement.

Financials and Funding

Incision has successfully secured funding to support its growth and innovation initiatives:

• Total Funds Raised: Approximately $13.06 million over two funding rounds.

• Recent Funding Rounds:

• Series A (2021): Raised $6.06 million.

• Series B (2023): Raised $7 million.

• Notable Investors: Alafi Capital and Dennendonck have been key investors in Incision's funding rounds.

The capital raised is intended to accelerate product development, expand market reach, and enhance technological capabilities, particularly in AI-driven solutions.

Pipeline Development

Incision's product pipeline includes several key offerings:

• Incision Assist: A digital platform that consolidates surgeon-specific workflows, preference cards, and OR-critical information into a single, intuitive application. This tool aims to streamline surgical preparation, reduce onboarding time, and improve turnover efficiency.

• Incision Academy: An accredited educational platform offering over 850 courses in surgery, surgical technology, and perioperative care. The Academy is recognized by the Royal College of Surgeons of England, ensuring high-quality, standards-aligned education for surgical teams.

• MySPD: A comprehensive program for sterile processing departments, combining digital competency tracking software with e-learning programs. MySPD supports staff development, certification, and compliance, enhancing performance and patient safety standards.

These products are in various stages of deployment, with Incision Assist and MySPD launched in 2021 and 2025, respectively. The company continues to develop and refine these offerings to meet the evolving needs of healthcare teams.

Technological Platform and Innovation

Incision distinguishes itself through several technological innovations:

• Proprietary Technologies: The ConfidentOR™ Knowledge Platform, which integrates critical surgical information into a unified application, enhancing team coordination and efficiency.

• Significant Scientific Methods: The use of AI for data modeling, workflow optimization, and product development, enabling smarter solutions that support surgical and sterile processing teams.

Leadership Team

Incision's leadership comprises experienced professionals from healthcare and digital innovation sectors:

• Ritsaart van Montfrans: Chief Executive Officer (CEO).

• Prof. Dr. Theo Wiggers, MD, PhD: Founder and Medical Director.

• Marian Scheer, MD, PhD: Chief Medical Officer.

• Jeff Perales: Chief Customer Officer.

• Eva Andriessen, MD: CEO of Incision USA.

• Femke van der Gaag: Managing Director BeNeLux.

• Robbert Wienen: Head of Product.

• Aimee Space, BSN, RN: Product Owner, US Medical Content.

• Mohamed Elshazly: Regional Director MEA.

These leaders bring a blend of medical expertise and digital innovation to drive Incision's mission forward.

Competitor Profile

Market Insights and Dynamics

The global healthcare technology market, particularly in surgical education and perioperative care, is experiencing significant growth. Advancements in digital solutions and AI integration are driving innovation and improving operational efficiencies in surgical settings.

Competitor Analysis

Incision operates in a competitive landscape with several key players:

• Medtronic: A leading competitor in the global laparoscopic device market, known for its diverse portfolio and advanced technologies.

• Ethicon: A subsidiary of Johnson & Johnson, specializing in wound closure products and known for its innovative sutures and staplers.

• Karl Storz: Specializes in reusable instruments and is a leader in the hand instruments, insufflation devices, and laparoscope market segments.

• Olympus: Competes directly with Medtronic and Ethicon in the direct energy and ultrasonic device markets and holds a significant share in the laparoscope market.

• Stryker: Dominates the suction-irrigation device market and offers competitive laparoscopes and hand instruments.

Strategic Collaborations and Partnerships

Incision has formed strategic partnerships to enhance its offerings:

• Levi9: A partnership that enabled Incision to accelerate technical innovation and product development, ensuring scalability and adaptability to evolving healthcare needs.

Operational Insights

Incision's focus on digital solutions and AI integration positions it uniquely in the market, offering tools that improve team confidence, clinical preparedness, and operational outcomes. This approach differentiates Incision from competitors by addressing the specific needs of perioperative teams through tailored digital platforms.

Strategic Opportunities and Future Directions

Incision's strategic roadmap includes:

• Expansion into New Markets: Entering the U.S. market in 2022 to reach a broader audience and tailor tools to meet the unique needs of American healthcare settings.

• Continuous Product Enhancement: Ongoing development of AI-driven solutions to better support surgical and sterile processing teams.

• Global Outreach: Leveraging strategic partnerships and technological innovations to expand Incision's global presence and impact in surgical education and performance enhancement.

Contact Information

• Website: www.incision.care

• LinkedIn: Incision LinkedIn Profile

• Twitter: Incision Twitter Profile

• Facebook: Incision Facebook Page

• Instagram: Incision Instagram Profile

Incision's commitment to innovation and quality positions it as a significant player in the healthcare technology sector, dedicated to enhancing surgical education and perioperative care worldwide.